NRC Health Debt Instrument, Interest Rate, Stated Percentage
NRC Health (NRC) had Debt Instrument, Interest Rate, Stated Percentage of 3.12% as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2013-11-07
- 2013-09-30: Debt Instrument, Interest Rate, Stated Percentage 3.12%.
- 2013-06-30: Debt Instrument, Interest Rate, Stated Percentage 3.12%.
- 2013-05-08: Debt Instrument, Interest Rate, Stated Percentage 3.79%.
- 2013-03-31: Debt Instrument, Interest Rate, Stated Percentage 3.79%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2013-09-30 | 3.12% 10-Q · filed 2013-11-07 |
| 2013-06-30 | 3.12% 10-Q · filed 2013-08-08 |
| 2013-05-08 | 3.79% 10-Q · filed 2013-11-07 |
| 2013-03-31 | 3.79% 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |